enGene Therapeutics Inc. (formerly enGene Holdings Inc.) filed to change its corporate name, effective April 8, 2026, with the announcement made on April 7, 2026. The company's common shares and warrants will continue trading under the same ticker symbols on Nasdaq: ENGN and ENGNW.